智通财经APP讯,白云山(00874)发布公告,于2025年2月28日,广州医药与兴证资管根据基础资产买卖协议(第四期)签订《新增基础资产交割确认函》,确认向兴证资管出售第二次新增基础资产,并收到购买价款人民币5.83亿元。
广州医药通过该等交易项下的交易利用应收账款进行资产证券化,可以将应收账款转变为流动性较高的现金资产,达到盘活资产存量的目的。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.